Rigol M, Solanes N, Farré J, Roura S, Roqué M, Berruezo A, Bellera N, Novensá L, Tamborero D, Prat-Vidal C, Huzman MA, Batlle M, Hoefsloot M, Sitges M, Ramírez J, Dantas AP, Merino A, Sanz G, Brugada J, Bayés-Genís A, Heras M
J. Card. Fail.. 2010 Apr;16(4):357-66, PMID: 20350704
Cell-based therapies offer a promising approach to reducing the short-term mortality rate associated with heart failure after a myocardial infarction. The aim of the study was to analyze histological and functional effects of adipose tissue-derived stem cells (ADSCs) after myocardial infarction and compare 2 types of administration pathways.
CARDIAC & CARDIOVASCULAR SYSTEMS